• Home
  • 3 columns
  • About Us
  • Advertise With Us
  • Checkout
  • Contact Us
  • Content
  • Cover Page
  • Distributors
  • Editorial
  • Home
  • Home 4
  • Home 5
  • Issue
  • Left sidebar
  • My account
  • My New Home
  • My Packages
  • Newsletter
  • Privacy Policy
  • Shop
  • Shortcodes
  • Subscribe

Logo

New Delhi Publishers

Navigation
  • Home
  • About Us
  • Editorial
  • Issue
  • Subscribe
  • Contact Us
  • Distributors
  • Advertise With Us

AstraZeneca is aiming to produce 2 billion doses of a coronavirus vaccine

New Vaccine

Pharmaceutical company AstraZeneca is aiming to produce 2 billion doses of a coronavirus vaccine, including 400 million for the U.S. and U.K. and 1 billion for those in low- and middle-income countries.

It plans to start distributing the vaccine to the U.S. and U.K. in September or October, with the balance of deliveries likely to be made by early 2021, according to AstraZeneca CEO Pascal Soriot, on a call with journalists Thursday.

AstraZeneca said it had signed a licensing deal with the Serum Institute of India to provide 1 billion doses to low- and middle-income countries, with 400 million of those shots set to be delivered by the end of 2020, according to a press release Thursday.

The vaccine, named AZD1222, was originally developed by Oxford University in the U.K. and AstraZeneca is working with pharmaceutical industry partners to manufacture and distribute the drug.

Soriot said the distribution was dependent on clinical trials taking place by August. Clinical trials and manufacturing are set to occur concurrently, which is an unprecedented move for the pharmaceutical industry because of the risk of producing a drug that might not work.

Share this story:
  • tweet

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

four × two =

Recommeded Books for NET,SET, JNU


DNA Digestion Experiment


Our Facebook Page

About Us

Bio Frontiers is a unique endeavor to chisel and shape contemporary outlooks in Biology. It is a Bi-monthly magazine dedicated to bringing the evolving facets of Biology to its wide gamut of readers. We focus on helping our readers to gain a better understanding of the fundamental concepts in Biology and develop on that. It is an undertaking “by the Biologists and for the growing Biologists”.

March 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Aug    

Locate Us

Contact Info

  • Bio Frontiers
    New Delhi Publishers
    Head Office: 90 Sainik Vihar, Mohan Garden,
    Uttam Nagar, New Delhi-110059
    Corporate Office: 7/28, Room No: 208,
    Vardaan House,Ansari Road,
    Daryaganj New Delhi-110002
  • Email: biofrontierse20@gmail.com
  • Website: https://bio-frontiers.com
Total Website Visits: 297731
© 2018. All Rights Reserved.